Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Владимир Иванович ПономаревfiledCriticalВладимир Иванович Пономарев
Priority to UAU200904069UpriorityCriticalpatent/UA43765U/en
Publication of UA43765UpublicationCriticalpatent/UA43765U/en
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
A method for treating the pathological addiction to the volatile solvents in the children and the adolescents provides for the complex pharmacological and non-medicamentous therapy. In addition, Finlepsin is used at a dose of 50 mg twice a day (for children aged 6-12) since the first day of the withdrawal syndrome for 3-4 days followed by the gradual decrease of the dose to 50 mg daily. For the adolescents aged 13-16, the initial dose is 100 mg twice a day followed by the gradual decrease of the dose to 100 mg daily.
UAU200904069U2009-04-272009-04-27Method for treating pathological addiction to volatile solvents in children and adolescents
UA43765U
(en)